Author: Shane Iles, Client Relationship Manager, Biocair UK
The landscape of logistics surrounding biological materials has changed rapidly - as have the regulatory frameworks around it. What has not necessarily kept pace is the end-user understanding of the nature of these logistical processes, their opportunities and their constraints.
Author: Tom Pettit, Global Vice President - Customer Solutions, Biocair US
Medicine has changed. Cell and gene therapies have created a requirement for personalized medicine, individual approaches to conditions that were previously treated via a top-down, one-size-fits-all system.